RBM8A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.886000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.174400E-01
Normal-vs-Stage2
5.656000E-01
Normal-vs-Stage3
7.900600E-01
Normal-vs-Stage4
2.326800E-01
Stage1-vs-Stage2
7.433200E-01
Stage1-vs-Stage3
5.341400E-01
Stage1-vs-Stage4
1.898610E-01
Stage2-vs-Stage3
2.760200E-01
Stage2-vs-Stage4
9.365800E-02
Stage3-vs-Stage4
1.861840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.064600E-01
Normal-vs-AfricanAmerican
2.958400E-01
Normal-vs-Asian
9.471200E-01
Caucasian-vs-AfricanAmerican
3.751000E-01
Caucasian-vs-Asian
3.709800E-01
AfricanAmerican-vs-Asian
9.748000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.565200E-01
Normal-vs-Female
6.364000E-01
Male-vs-Female
6.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.490400E-01
Normal-vs-Age(41-60Yrs)
3.437200E-01
Normal-vs-Age(61-80Yrs)
7.239400E-01
Normal-vs-Age(81-100Yrs)
6.395000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.111800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.648400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.217800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.070300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.124800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.921400E-01
Normal-vs-Daily Drinker
9.460400E-01
Normal-vs-Weekly Drinker
7.466400E-01
Normal-vs-Occasional Drinker
1.181040E-01
Normal-vs-Social Drinker
6.663400E-01
Non Drinker-vs-Daily Drinker
5.241200E-01
Non Drinker-vs-Weekly Drinker
9.880800E-01
Non Drinker-vs-Occasional Drinker
3.588000E-02
Non Drinker-vs-Social Drinker
8.901800E-01
Daily Drinker-vs-Weekly Drinker
6.361800E-01
Daily Drinker-vs-Occasional Drinker
1.652460E-02
Daily Drinker-vs-Social Drinker
6.499600E-01
Weekly Drinker-vs-Occasional Drinker
9.325900E-02
Weekly Drinker-vs-Social Drinker
9.221200E-01
Occasional Drinker-vs-Social Drinker
2.605900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.147200E-01
Normal-vs-Grade 2
3.238400E-02
Normal-vs-Grade 3
1.599860E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.003900E-02
Grade 1-vs-Grade 3
9.342900E-03
Grade 1-vs-Grade 4
2.147200E-01
Grade 2-vs-Grade 3
2.608400E-01
Grade 2-vs-Grade 4
3.238400E-02
Grade 3-vs-Grade 4
1.599860E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.117000E-01
Normal-vs-NonDiabetic
5.534600E-01
Diabetic-vs-NonDiabetic
1.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.056400E-01
Normal-vs-NoPancreatitis
6.122800E-01
Pancreatitis-vs-NoPancreatitis
5.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.244200E-01
Normal-vs-N1
6.091400E-01
N0-vs-N1
5.730400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.759230E-01
Normal-vs-TP53-NonMutant
8.044800E-01
TP53-Mutant-vs-TP53-NonMutant
4.782900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
